4.4 Article

TcsL Is an Essential Virulence Factor in Clostridium sordellii ATCC 9714

期刊

INFECTION AND IMMUNITY
卷 79, 期 3, 页码 1025-1032

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/IAI.00968-10

关键词

-

资金

  1. Australian National Health and Medical Research Council
  2. National Institutes of Health [HD057176]

向作者/读者索取更多资源

Clostridium sordellii is an important pathogen of humans and animals, causing a range of diseases, including myonecrosis, sepsis, and shock. Although relatively rare in humans, the incidence of disease is increasing, and it is associated with high mortality rates, approaching 70%. Currently, very little is known about the pathogenesis of C. sordellii infections or disease. Previous work suggested that the lethal large clostridial glucosylating toxin TcsL is the major virulence factor, but a lack of genetic tools has hindered our ability to conclusively assign a role for TcsL or, indeed, any of the other putative virulence factors produced by this organism. In this study, we have developed methods for the introduction of plasmids into C. sordellii using RP4-mediated conjugation from Escherichia coli and have successfully used these techniques to insertionally inactivate the tcsL gene in the reference strain ATCC 9714, using targetron technology. Virulence testing revealed that the production of TcsL is essential for the development of lethal infections by C. sordellii ATCC 9714 and also contributes significantly to edema seen during uterine infection. This study represents the first definitive identification of a virulence factor in C. sordellii and opens the way for in-depth studies of this important human pathogen at the molecular level.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Microbiology

Comparative Transcriptomic and Functional Assessments o Linezolid-Responsive Small RNA Genes in Staphylococcus aureus

Wei Gao, Romain Guerillot, Ya Hsun Lin, Jai Tree, Marie Beaume, Patrice Francois, Ian R. Monk, Torsten Seemann, Jacques Schrenzel, Benjamin P. Howden, Timothy P. Stinear

MSYSTEMS (2020)

Article Reproductive Biology

Machine learning on drug-specific data to predict small molecule teratogenicity

Anup P. Challa, Andrew L. Beam, Min Shen, Tyler Peryea, Robert R. Lavieri, Ethan S. Lippmann, David M. Aronoff

REPRODUCTIVE TOXICOLOGY (2020)

Article Immunology

Cytotrophoblasts suppress macrophage-mediated inflammation through a contact-dependent mechanism

Alison J. Eastman, Erin N. Vrana, Maria T. Grimaldo, Amanda D. Jones, Lisa M. Rogers, Donald J. Alcendor, David M. Aronoff

Summary: The study found that chorion-derived trophoblasts (CTBs) can suppress inflammation in macrophages (M phi) through an as-yet unknown cell-to-cell contact-mediated mechanism, and this immunosuppression is also influenced by physical contact.

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2021)

Article Pharmacology & Pharmacy

The Influence of Obesity and Associated Fatty Acids on Placental Inflammation

Alison J. Eastman, Rebecca E. Moore, Steven D. Townsend, Jennifer A. Gaddy, David M. Aronoff

Summary: This review examines how maternal obesity and associated fatty acids influence placental inflammation. Findings suggest that palmitate, commonly used in in vitro studies, induces negative effects on placental cells, while obesity as a whole may have more complex regulation mechanisms due to the presence of unsaturated fatty acids.

CLINICAL THERAPEUTICS (2021)

Article Biotechnology & Applied Microbiology

Stable Recombinant-Gene Expression from a Ligilactobacillus Live Bacterial Vector via Chromosomal Integration

Ben Vezina, Theo Allnutt, Anthony L. Keyburn, Ben Wade, Thi Thu Hao Van, Priscilla Johanesen, Dena Lyras, Robert J. Moore

Summary: Disease control in animal production systems necessitates constant vigilance. The widespread use of in-feed antibiotics is believed to increase the risk of antibiotic resistance, prompting the development of alternative methods. Live vaccination proves effective in preventing mucosa-dwelling pathogens by inducing mucosal immunity.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2021)

Article Multidisciplinary Sciences

AusTrakka: Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic

Tuyet Hoang, Anders Goncalves da Silva, Amy Jennison, Deborah A. Williamson, Benjamin P. Howden, Torsten Seemann

Summary: The COVID-19 pandemic has driven the development of Australia's pathogen genomics platform AusTrakka, enabling rapid data sharing and real-time genomic surveillance.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Optimising genomic approaches for identifying vancomycin-resistant Enterococcus faecium transmission in healthcare settings

Charlie Higgs, Norelle L. Sherry, Torsten Seemann, Kristy Horan, Hasini Walpola, Paul Kinsella, Katherine Bond, Deborah A. Williamson, Caroline Marshall, Jason C. Kwong, M. Lindsay Grayson, Timothy P. Stinear, Claire L. Gorrie, Benjamin P. Howden

Summary: The researchers developed a standardized genomic method to identify transmission links of vancomycin-resistant Enterococcus faecium (VREfm). They found that clustering by core genome multilocus sequence type (cgMLST) provided more informative population structure than traditional MLST, and pairwise genome comparisons using split k-mer analysis (SKA) were effective in inferring patient-to-patient transmission. This study provides a standardized genomic framework for VREfm transmission detection, which can be globally deployed for outbreak detection and investigation.

NATURE COMMUNICATIONS (2022)

Review Pharmacology & Pharmacy

Evaluating the Risks of Systemic Maternal Ivermectin Exposure During Pregnancy in Human and Vertebrate Animals: A Scoping Review

Camille S. Westlake, David M. Aronoff

Summary: A scoping review was conducted to evaluate the safety of systemic ivermectin exposure during pregnancy in both human and vertebrate animal studies. High doses were associated with adverse pregnancy outcomes in mice, rats, and rabbits, but therapeutic doses did not show significant associations with adverse birth outcomes in humans. Further research is needed to address safety concerns regarding the use of ivermectin in pregnant women.

CURRENT DRUG SAFETY (2021)

Article Public, Environmental & Occupational Health

Disruption of medical care among individuals in the southeastern United States during the COVID-19 pandemic

Bin Ni, Erin Gettler, Rebecca Stern, Heather M. Munro, Mark Steinwandel, Melinda C. Aldrich, Debra L. Friedman, Maureen Sanderson, David Schlundt, David M. Aronoff, Deepak K. Gupta, Martha J. Shrubsole, Loren Lipworth

Summary: Disruptions to healthcare during the COVID-19 pandemic were primarily driven by health system-initiated deferrals and individual perceptions of COVID-19 risk, disproportionately affecting different population groups.

JOURNAL OF PUBLIC HEALTH RESEARCH (2022)

Review Microbiology

Impact of enteric bacterial infections at and beyond the epithelial barrier

Ashleigh P. Rogers, Steven J. Mileto, Dena Lyras

Summary: The mucosal lining of the gut has evolved specialized mechanisms to limit the invasion of pathogens, but some microorganisms have adapted and breached the gut barrier. This breach not only leaks host factors but can also lead to detrimental systemic events. This review examines the impact of enteric bacterial infections on the gut barrier and beyond, including disruption of defenses, systemic dissemination, inflammatory processes, and barrier regeneration.

NATURE REVIEWS MICROBIOLOGY (2023)

Article Biochemistry & Molecular Biology

Host inflammatory dynamics reveal placental immune modulation by Group B Streptococcus during pregnancy

Felicia Kuperwaser, Gal Avital, Michelle J. Vaz, Kristen N. Noble, Allison N. Dammann, Tara M. Randis, David M. Aronoff, Adam J. Ratner, Itai Yanai

Summary: Group B Streptococcus (GBS) is a pathobiont that ascends to the placenta and causes adverse pregnancy outcomes by producing the toxin beta-hemolysin/cytolysin (beta-h/c). This study shows that GBS modulates the state of innate immune cells by subverting host inflammation through beta-h/c, leading to worse outcomes.

MOLECULAR SYSTEMS BIOLOGY (2023)

Article Microbiology

Improved Genome Sequence of Australian Methicillin-Resistant Staphylococcus aureus Strain JKD6159

Ryan R. Wick, Louise M. Judd, Ian R. Monk, Torsten Seemann, Timothy P. Stinear

Summary: This report presents an improved assembly of the genome sequence of a prominent community-acquired methicillin-resistant Staphylococcus aureus (MRSA) clone in Australia. The assembly was achieved through deep sequencing with multiple technologies and careful curation, resulting in an error-free sequence.

MICROBIOLOGY RESOURCE ANNOUNCEMENTS (2023)

Review Peripheral Vascular Disease

Antihypertensives and Antibiotics: Impact on Intestinal Dysfunction and Hypertension

Sarah E. Lucas, Sarah L. Walton, Katrina M. Mirabito M. Colafella, Steven J. Mileto, Dena Lyras, Kate M. Denton

Summary: Gut dysfunction is identified as a contributor to hypertension and its related diseases. The breakdown of the homeostatic relationship involving intestinal epithelial function, microbiota and immune responses is crucial. Antihypertensive medications have shown potential in reversing intestinal dysfunction and dysbiosis but the underlying mechanisms remain unclear.

HYPERTENSION (2023)

Article Multidisciplinary Sciences

Nonsteroidal anti-inflammatory drugs sensitize epithelial cells to Clostridioides difficile toxin-mediated mitochondrial damage

Joshua Soto Ocana, Nile U. Bayard, Jessica L. Hart, Audrey K. Thomas, Emma E. Furth, D. Borden Lacy, David M. Aronoff, Joseph P. Zackular

Summary: Clostridioides difficile damages the colonic mucosa through potent exotoxins. The factors contributing to C. difficile pathogenesis are not fully understood, but likely involve ecological, immune, and environmental factors. Recent studies have shown that nonsteroidal anti-inflammatory drugs exacerbate C. difficile infection, although the mechanism behind this is unclear.

SCIENCE ADVANCES (2023)

Article Medicine, Research & Experimental

Medication history-wide association studies for pharmacovigilance of pregnant patients

P. Challa Anup, Xinnan Niu, Etoi A. Garrison, Sara L. Van Driest, Lisa M. Bastarache, Ethan S. Lippmann, Robert R. Lavieri, Jeffery A. Goldstein, David M. Aronoff

Summary: Pregnant people have been systematically excluded from clinical trials, resulting in a lack of safety data for common drugs. This study used electronic health records to investigate the effects of maternal exposure to different drugs on neurodevelopmental defects in their children, and proposed an agile framework for improving medication regulations.

COMMUNICATIONS MEDICINE (2022)

暂无数据